Mutational Signature Indicates Risk of Kidney Cancer Recurrence
Mutational Signature Indicates Risk of Kidney Cancer Recurrence
DNA sequencing can identify mutations that predict recurrence of renal cell carcinoma and may help low-risk patients avoid unnecessary treatment, a study finds.
DNA sequencing can identify mutations that predict recurrence of renal cell carcinoma and may help low-risk patients avoid unnecessary treatment, a study finds.
renal cell carinoma
How Kidney Cancer Evolves
Jim Daley | Apr 18, 2018 | 2 min read
Renal cell carcinoma tumors have three different evolutionary fates, each associated with specific clinical outcomes.